Publicações Selecionadas

Fortmann SP, Williams PT, Hulley SB, Haskell WL, Farquhar JW. Effect of health education on dietary behavior: The Stanford Three Community Study.  Am J Clin Nutr 1981;34:2030-2038.

Fortmann SP, Williams PT, Hulley SB, Maccoby N, Farquhar JW. Does dietary health education reach only the privileged? An answer from the Stanford Three Community Study.  Circulation 1982;66:77-82.

Fortmann SP, Haskell WL, Vranizan K, Brown BW. The association of blood pressure and dietary alcohol: differences by age, sex, and estrogen use.  Am J Epidemiol 1983;118:497-507.

Fortmann SP, Sallis JF, Magnus PM, Farquhar JW. Attitudes and practices of physicians regarding hypertension and smoking: The Stanford Five-City Project.  Prev Med 1985;14:70-80.

Fortmann SP, Haskell WL, Williams PT, Varady AN, Hulley SB, Farquhar JW.  Community surveillance of cardiovascular diseases in the Stanford Five City Project: Methods and initial experience. Am J Epidemiol 1986;123:656-69.

Fortmann SP, Killen JD, Telch MJ, Newman B. Minimal contact treatment for smoking cessation:  a placebo-controlled trial of nicotine polacrilex and self-directed relapse prevention. JAMA 1988; 260:1575-1580.

Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Maccoby N, Wood PD. Effects of communitywide education on cardiovascular disease risk factors: The Stanford Five-City Project:  JAMA 1990;264:359-365.

Fortmann SP, Winkleby MA, Flora JA, Haskell WL, Taylor CB. Effect of long-term community health education on blood pressure and hypertension control: The Stanford Five-City Project. Am J Epidemiol 1990;132:629-646.

Fortmann SP, Taylor CB, Flora JA, Jatulis DE. Changes in adult cigarette smoking prevalence after 5 years of community health education: The Stanford Five-City Project.  Am J Epidemiol 1993;137:82-96.

Fortmann SP, Killen JD. Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. Am J Epidemiol 1994;140:39-51.

Fortmann SP, Killen JD. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psych 1995; 63:460-468.

Fortmann SP, Breitrose PE. The Blood Pressure Book. Palo Alto, CA: Bull Publishing Company, 1996.

Dobson AJ, Kuulasmaa K, Moltchanov V, Evans A, Fortmann SP, Jamrozik K, Sans S, Tuomilehto J, for the WHO MONICA Project. Changes in cigarette smoking among adults in 35 populations in the mid-1980s. Tobacco Control 1998; 7:14-21.

Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J for the WHO MONICA Project. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet 2000; 355:675-687.

Fortmann SP, Varady AN. Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: The Stanford Five-City Project. Am J Epidemiol  2000; 152: 316–323.

Carnethon M, Palaniappan L, Burchfiel C, Brancati F, Fortmann SP. Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: The Atherosclerosis Risk in Communities Study, 1987–1998. Diabetes Care 2002; 25: 1358-1364.

Killen JD, Fortmann SP, Kraemer HC, Varady A. Do men outperform women in smoking cessation studies? Maybe - but not by much. Experimental and Clinical Psychopharmacology 2002; 10: 295-301.

Henriksen L, Flora JA, Feighery EC, Fortmann SP. Effects on youth of exposure to retail tobacco advertising. J Applied Social Psych 2002; 32: 1771-1789.

Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE. Risk factors for progression to incident hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987 – 1998. Am J Epidemiol 2003; 158:1058-1067.

Henriksen L, Feighery EC, Wang Y, Fortmann SP. Association of retail tobacco marketing with adolescent smoking. Am J Public Health 2004; 94: 2081-2083.

Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous, T, Hlatky MA for the Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study. Statin and ß-blocker therapy and the initial presentation of Coronary Heart Disease. Ann Intern Med 2006; 144: 229-238.

Killen JD, Fortmann SP, Murphy GM, Hayward C, Arredondo CJ, Cromp D, Celio M, Abe L, Wang Y, Schatzberg AF. Efficacy of extended treatment with bupropion for cigarette smoking cessation. J Consult Clin Psych 2006; 74: 286-294.